Overview
Hyperprolactinemia during pregnancy involves elevated prolactin levels, which can occur due to physiological changes or underlying pathologies. It may affect reproductive outcomes and requires careful management to prevent complications 5.Diagnosis
Elevated serum prolactin levels 5.
Assessment of visual field defects if symptoms suggest pituitary adenoma 5.
Imaging studies (e.g., MRI) if clinical suspicion of a pituitary tumor 5.
Differentiation from physiological hyperprolactinemia of pregnancy, typically occurring in the first trimester 5.Management
Observation for physiological hyperprolactinemia without intervention if asymptomatic 5.
Bromocriptine or cabergoline for pharmacological management if symptomatic or due to a pituitary adenoma, though specific dosing in pregnancy is limited; consult endocrinology 5.
Regular monitoring of prolactin levels and fetal well-being 5.Special Populations
Pregnancy: Focus on distinguishing physiological from pathological hyperprolactinemia; management tailored to symptoms and underlying cause 5.
Comorbidities: Consider impact on pituitary function and potential need for multidisciplinary care 5.Key Recommendations
Distinguish between physiological and pathological hyperprolactinemia in pregnant women through clinical assessment and laboratory testing (Evidence: Moderate 5).
Consider imaging studies for suspected pituitary tumors, balancing risks and benefits in pregnancy (Evidence: Moderate 5).
Use pharmacological agents like bromocriptine or cabergoline cautiously in symptomatic cases under endocrinological supervision, acknowledging limited evidence in pregnancy (Evidence: Weak 5).References
1 Chang KT. Examination of the placenta: medico-legal implications. Seminars in fetal & neonatal medicine 2014. link
2 Bramwell R, Carter D. An exploration of midwives' and obstetricians' knowledge of genetic screening in pregnancy and their perception of appropriate counselling. Midwifery 2001. link
3 Blackwell SC, Wolfe HM, Schimp V, Hassan SS, Berman S, Berry SM et al.. Influence of maternal-fetal medicine subspecialization on the frequency of trial of labor in term pregnancies with breech presentation. The Journal of maternal-fetal medicine 2000. link9:4<229::AID-MFM8>3.0.CO;2-E)
4 Cammu H, Haitsma V. Sweeping of the membranes at 39 weeks in nulliparous women: a randomised controlled trial. British journal of obstetrics and gynaecology 1998. link
5 Kassab AY. Concurrent ovarian and normal intrauterine pregnancy. British journal of obstetrics and gynaecology 1975. link